By Jamie Lennox ( November 12, 2025, 7:47 PM GMT) -- The German pharmaceuticals company Aristo has asked a London court to invalidate Takeda's extended patent protections in the U.K. over the ADHD treatment Elvanse....
German Pharma Co. Says Takeda's ADHD Drug IP Isn't Valid
Law360 UK1 hrs ago
49


Cambridgeshire Live
iNews
The Spectator
Legal Futures
iNews Opinion
The Daily Mash
Britain News
Raw Story
NPR